Telehealth: CB Scientific (CBSC) Acquires Prevent Health Care International Corp.
CB Scientific, Inc. (CBSC) Announces Completion of Asset Purchase Agreement and Commencement of Its ECG Monitoring Business.
Adding Dalrada (DFCO) $0.09 to CoronaVirus Stock Watch List.
LIVE QUOTE
Adding Dalrada (DFCO), a technology Incubator with interests in telehealth and...
Video: Hapbee Testimonials.
Hapbee is powered by patented ultra-low radio frequency energy (ulRFE®) technology invented by...
Citius Pharma (CTXR) Video Presentation.
Chairman Leonard Mazur Discusses:
Mino-Lok Treatment for Infected Catheters.
Novellus Stem Cell Treatment...
Magic Mushroom Compass Pathways (CMPS) IPO Valued at Near $1 Billion.
Shares jumped 71% to $29 in New York after an initial public offering of 7.5 million shares priced at $17 each...
Adding Sorrento Therapeutics (SRNE) to CoronaVirus Watch List.
LIVE QUOTE
Of course, we need not have to say, this is not an idea for widows...
Hy-IQ Trademark
REGISTERED 9-15-2020
Aphex BioCleanse Systems (APHX) Plans Filing With Securities & Exchange Commission.
Aphex BioCleanse Systems Appoints Hancock Askew as New PCAOB-Qualified Auditor, Hires Accounting Consultant
PITTSFORD, N.Y., Sept 14, 2020 /PRNewswire/ -- Aphex...
Immunomedics (IMMU) $3.00 to $88, Up 29-fold, Our Second Best Idea Ever.
Interesting Charts From the Day we Discovered it.
Gilead Sciences, Inc. (Nasdaq: GILD) and Immunomedics (Nasdaq: IMMU) announced...
American BriVision’s (ABVC) Clinical Study Sparks Interest From Potential Partners.
Is Wall Street Missing American Brivision's Full Clinical Safety and Efficacy Study? We Think it has.
Potential...
Latest article
We’re in Tampa for the Kentucky Derby.
GeoVax (GOVX), Sees a Little Volume.
Normally, we get a little nervous when one of the companies we...
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
